Dr Troy William Trayer, DO | |
2605 Keiser Blvd, Wyomissing, PA 19610-3338 | |
(610) 685-8500 | |
(610) 685-4833 |
Full Name | Dr Troy William Trayer |
---|---|
Gender | Male |
Speciality | Interventional Cardiology |
Experience | 17 Years |
Location | 2605 Keiser Blvd, Wyomissing, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689842049 | NPI | - | NPPES |
OT012116 | Other | PA | STATE LISCENCE |
D09619700 | Other | NJ | CDS |
25MB08709000 | Other | NJ | STATE LICENSE |
OS016928 | Other | PA | STATE LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | OS016928 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Joseph Medical Center | Reading, PA | Hospital |
Reading Hospital | West reading, PA | Hospital |
Milton S Hershey Medical Center | Hershey, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Penn State Health Community Medical Group Llc | 8729351077 | 646 |
News Archive
Imagine a "smart pill" containing a biodegradable electronic chip that monitors how your body responds to the medicine, broadcasts the information to your iPhone, which then emails the information to your physician.
Researchers of the Sarcoma research group of the Bellvitge Biomedical Research Institute, led by Dr. Òscar Martínez-Tirado, have first described the methylation profile of Ewing's sarcoma, a cancer of bone and soft tissues that mainly affects children and teenagers.
Catalyst Pharmaceutical Partners, Inc. today announced that the Company will continue to develop CPP-109 (Catalyst's version of vigabatrin) for the treatment of cocaine and methamphetamine addiction.
With BackCare Awareness Week reiterating the fact that 80 per cent of people, who work across all industries and professions, will suffer from back pain at some point in their lives, workplace equipment supplier Slingsby says that nearly all work related back pain can be avoided.
› Verified 4 days ago
Entity Name | The Milton S Hershey Medical Center Physicians Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710951744 PECOS PAC ID: 3870405483 Enrollment ID: O20040225000741 |
News Archive
Imagine a "smart pill" containing a biodegradable electronic chip that monitors how your body responds to the medicine, broadcasts the information to your iPhone, which then emails the information to your physician.
Researchers of the Sarcoma research group of the Bellvitge Biomedical Research Institute, led by Dr. Òscar Martínez-Tirado, have first described the methylation profile of Ewing's sarcoma, a cancer of bone and soft tissues that mainly affects children and teenagers.
Catalyst Pharmaceutical Partners, Inc. today announced that the Company will continue to develop CPP-109 (Catalyst's version of vigabatrin) for the treatment of cocaine and methamphetamine addiction.
With BackCare Awareness Week reiterating the fact that 80 per cent of people, who work across all industries and professions, will suffer from back pain at some point in their lives, workplace equipment supplier Slingsby says that nearly all work related back pain can be avoided.
› Verified 4 days ago
Entity Name | Penn State Health Community Medical Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861988644 PECOS PAC ID: 8729351077 Enrollment ID: O20170907002279 |
News Archive
Imagine a "smart pill" containing a biodegradable electronic chip that monitors how your body responds to the medicine, broadcasts the information to your iPhone, which then emails the information to your physician.
Researchers of the Sarcoma research group of the Bellvitge Biomedical Research Institute, led by Dr. Òscar Martínez-Tirado, have first described the methylation profile of Ewing's sarcoma, a cancer of bone and soft tissues that mainly affects children and teenagers.
Catalyst Pharmaceutical Partners, Inc. today announced that the Company will continue to develop CPP-109 (Catalyst's version of vigabatrin) for the treatment of cocaine and methamphetamine addiction.
With BackCare Awareness Week reiterating the fact that 80 per cent of people, who work across all industries and professions, will suffer from back pain at some point in their lives, workplace equipment supplier Slingsby says that nearly all work related back pain can be avoided.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Troy William Trayer, DO 2605 Keiser Blvd, Wyomissing, PA 19610-3338 Ph: (610) 685-8500 | Dr Troy William Trayer, DO 2605 Keiser Blvd, Wyomissing, PA 19610-3338 Ph: (610) 685-8500 |
News Archive
Imagine a "smart pill" containing a biodegradable electronic chip that monitors how your body responds to the medicine, broadcasts the information to your iPhone, which then emails the information to your physician.
Researchers of the Sarcoma research group of the Bellvitge Biomedical Research Institute, led by Dr. Òscar Martínez-Tirado, have first described the methylation profile of Ewing's sarcoma, a cancer of bone and soft tissues that mainly affects children and teenagers.
Catalyst Pharmaceutical Partners, Inc. today announced that the Company will continue to develop CPP-109 (Catalyst's version of vigabatrin) for the treatment of cocaine and methamphetamine addiction.
With BackCare Awareness Week reiterating the fact that 80 per cent of people, who work across all industries and professions, will suffer from back pain at some point in their lives, workplace equipment supplier Slingsby says that nearly all work related back pain can be avoided.
› Verified 4 days ago
Nirav R. Shah, MD, MPH Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1011 Reed Ave, Suite 300, Wyomissing, PA 19610 Phone: 610-374-4401 Fax: 610-374-7140 | |
Dr. David F Steffy, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 950b N Wyomissing Blvd, 3rd Floor, Wyomissing, PA 19610 Phone: 610-898-1820 Fax: 610-372-0164 | |
Dr. Michael Bernard Russo, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2605 Keiser Blvd, Wyomissing, PA 19610 Phone: 610-685-8500 Fax: 610-685-4833 | |
Dr. Pallak Agarwal, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2608 Keiser Blvd, Wyomissing, PA 19610 Phone: 610-685-5864 Fax: 610-929-1528 | |
Dr. Kristie Marie Pepper, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2760 Century Blvd, Wyomissing, PA 19610 Phone: 610-375-4251 Fax: 610-685-2870 | |
Louis La Luna, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1011 Reed Ave, Suite 300, Wyomissing, PA 19610 Phone: 610-374-4401 Fax: 610-374-7140 | |
Tara Lynn Dimino, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2605 Keiser Blvd, Wyomissing, PA 19610 Phone: 610-685-8500 Fax: 610-685-4833 |